Kinase inhibitors

Patent number:

WO2010119264 (A1)

Comunidad de Madrid.svg
No items found.

The CNIO has developed novel pharmaceutical compounds, which are useful as inhibitors of protein or lipid kinases, such as inhibitors of the phosphoinositide 3OH kinase (PI3 kinase) family, particularly the PI3K class I sub-type, or, inhibitors of the mammalian target of rapamycin (mTOR). The inventors have found a novel set of compounds useful in the treatment of diseases in which inhibition of a protein or lipid kinase (e.g. a PI3-K and/or mTOR) is desired and/or required, and particularly in the treatment of cancer or a proliferative disease.

Countries:
Spain
Regions:
Community of Madrid
Centers:
CENTRO NACIONAL DE INVESTIGACEIONES ONCOLOGICAS CNIO, SPANISH NATIONAL CANCER RESEARCH CENTRE
Other entities:
Sectors:
Health
Subsectors:
Biotechnology
TRL Level:
TRL 4 – technology validated in lab
BRL Level:
PDF Link:
Download here
Video Link:
Watch it here
Sustainable Development Goal:
Applications

Compounds of the invention are effective inhibitors of protein or lipid kinases, e.g. PI3K, such as class I PI3K, and/or mTOR. The invention also relates to the use of such compounds as medicaments, to the use of such compounds for the treatment of a disease in which the inhibition of such protein or lipid kinases is desired and/or required such as cancer, to pharmaceutical compositions containing them, and to synthetic routes for their production.

Comments

Other related patents

Circular Economy
Chemicals
Health

CO2 CAPTURE USING ALKALINE MEDIA FOR THE PREPARATION OF SODIUM CARBONATE

Countries
No items found.
Know more
Health

DETECTION AND MUTATIONAL ANALYSIS OF AN RNA VIRUS IN AN ENVIRONMENTAL SAMPLE

Countries
Greece
Know more
Chemicals
Health

Production of hyaluronic acid oligosaccharides using a novel fungal enzyme

Countries
Spain
Know more
Get back to patents directory